During the past decade, VIN-Victor Faradji conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "VIN-Victor Faradji" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Bial - Portela C S.A." with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Sunovion" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "VIN-Victor Faradji" #1 collaborator was "Pfizer" with 1 trials as a collaborator and "Sunovion" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "VIN-Victor Faradji" are "Alzheimer Disease" (2 trials), "Alzheimer Disease (AD)" (1 trials), "Epilepsy" (1 trials), "Lewy Body Dementia" (1 trials) and "Mild to Severe Alzheimer's Disease" (1 trials). Many other conditions were trialed in "VIN-Victor Faradji" in a lesser frequency.

Most popular intervention types in "VIN-Victor Faradji" are "Drug" (7 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "1200 mg QD Eslicarbazepine acetate" (1 trials), "800 mg QD Eslicarbazepine acetate" (1 trials), "Donanemab" (1 trials) and "Donepezil HCl" (1 trials). Other intervention names were less common.

The vast majority of trials in "VIN-Victor Faradji" are 8 trials for "All" genders.

Currently, there are NaN active trials in "VIN-Victor Faradji". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in VIN-Victor Faradji, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in VIN-Victor Faradji, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

VIN-Victor Faradji has several departments that took part in Clinical trials: "Neurology Offices of South Florida" - 14 trials, "Aventura Neurological Associates" - 5 trials, "Neurological Associates" - 2 trials